Cancers · 2024 · 12 citations · 52 references
MedicineHematologyMolecular MedicineHematologic OncologyMolecular OncologyPrecision MedicineBone Marrow PathologyHematologic MalignanciesHematologic Malignancy TherapyHematopoietic NeoplasmsMyelodysplastic SyndromesTumor ClassificationGenomic Alteration ProfilingGenomic Imbalance ProfilingMyelodysplastic Syndrome TherapyMyelodysplastic Syndrome TreatmentMyeloid NeoplasmsPrognostic Grading SystemsPrognostic Molecular StratificationPrognostic Staging Systems
Myelodysplastic syndromes/neoplasms (MDSs) encompass a range of hematopoietic malignancies, commonly affecting elderly individuals. Molecular alterations in the hematopoietic stem cell compartment drive disease pathogenesis. Recent advancements in genomic profiling have provided valuable insights into the biological underpinnings of MDSs and have expanded therapeutic options, particularly for specific molecularly defined subgroups. This review highlights the diagnostic principles, classification updates, prognostic stratification systems, and novel treatments, which could inform future clinical trials and enhance the management of adult MDS patients, particularly for specific molecularly defined subgroups.
52
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg, Heinz Tuechler, Julie Schanz et al. · Blood · 2012 · 3.1K citations · Full text
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Elsa Bernard, Heinz Tuechler, Peter L. Greenberg et al. · NEJM Evidence · 2022 · 813 citations · Full text
Medicine, Genetics, Hematology +16